WHR
61
3
CHD
34
7
AMG
33
-11
THC
52
9
AIG
38
5
ADBE
50
3
PM
49
8
PNW
55
3
UNH
42
6
PFG
27
7
FTI
61
5
AMAT
33
3
PHM
44
4
CMA
42
3
SJM
17
5
CNX
67
4
NTAP
58
3
CMS
57
2
DD
44
2
MCO
67
3
WHR
61
3
CHD
34
7
AMG
33
-11
THC
52
9
AIG
38
5
ADBE
50
3
PM
49
8
PNW
55
3
UNH
42
6
PFG
27
7
FTI
61
5
AMAT
33
3
PHM
44
4
CMA
42
3
SJM
17
5
CNX
67
4
NTAP
58
3
CMS
57
2
DD
44
2
MCO
67
3
Financhill
Back

Barinthus Biotherapeutics PLC 10K Form

Sell
33

BRNS
Barinthus Biotherapeutics PLC

Last Price:
$1.07
Seasonality Move:
-10.58%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BRNS News And Ratings

See the #1 stock for the next 7 days that we like better than BRNS

BRNS Financial Statistics

Sales & Book Value

Annual Sales: $802K
Cash Flow: $-18.3M
Price / Cash Flow: 0
Annual Sales: $4.03
Price / Book: 0.26

Profitability

EPS (TTM): -1.49000
Net Income (TTM): $-57.8M
Gross Margin: --
Return on Equity: -33.2%
Return on Assets: -28.36%

Barinthus Biotherapeutics PLC Earnings Forecast

Key Barinthus Biotherapeutics PLC Financial Ratios

  • The Research & Development expenses have been 5,163.72% of Revenue.
  • The Interest Expense is -0.04% of Operating Income.
  • The Net Earning history of BRNS is -9,145.51% of Total Revenues.
  • Per Share Earnings over the last 4 years have been positive in 2 years.

Barinthus Biotherapeutics PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: BRNS
Website: barinthusbio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 8.93
Quick Ratio: 8.9

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BRNS Technical Analysis vs Fundamental Analysis

Sell
33
Barinthus Biotherapeutics PLC (BRNS) is a Sell

Is Barinthus Biotherapeutics PLC a Buy or a Sell?